Skip to main content
. 2016 Dec 3;18:289. doi: 10.1186/s13075-016-1192-x

Fig. 1.

Fig. 1

a-b Distribution of anti-carbamylated protein (anti-CarP)-positive, anti-cyclic citrullinated peptide (anti-CCP)-positive and anti-cyclic arginine peptide (anti-CAP)-positive patients in the discovery cohort (n = 236) (a), and in the replication cohort (n = 205) (b)